跳至主要内容
临床试验/NCT05246813
NCT05246813招募中不适用

Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP): a Prospective Observational Study

Imelda Hospital, Bonheiden1 个研究点 分布在 1 个国家目标入组 24 人开始时间: 2022年2月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
24
试验地点
1
主要终点
Gene Set Enrichment Analysis (GSEA) Normalized Enrichment Score (NES)

研究概览

简要总结

Bone marrow samples will be collected from patients undergoing hip arthroplasty surgery. Blood and bone marrow samples will be used for metabolic profiling and analysis of relevant CHIP mutations. Combined single-cell transcriptomics and mutation-specific single-cell genotyping (biotin-PCR using mutation-targeted primers followed by sequencing) will subsequently be performed. The gene expression profile of wildtype and mutant hematopoietic stem cells will be compared, performing both broad gene set enrichment analysis and targeted analysis of metabolic pathways.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 65 years and older

排除标准

  • known haematological condition (myelodysplasia, leukemia, cancer)
  • inability to provide written informed consent

结局指标

主要结局

Gene Set Enrichment Analysis (GSEA) Normalized Enrichment Score (NES)

时间窗: One day

次要结局

未报告次要终点

研究者

发起方
Imelda Hospital, Bonheiden
申办方类型
Other
责任方
Principal Investigator
主要研究者

Michaël R Laurent, MD PhD

Principal Investigator

Imelda Hospital, Bonheiden

研究点 (1)

Loading locations...

相似试验